Woodford Investment Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,350,719	Closed	-$221M	–	2
2019 Q3	$221M	Sell	11,350,719 -809,261	-7%	-$16.4M	71.3%	1
2019 Q2	$199M	Sell	12,159,980 -1,219,999	-9%	-$24.7M	33.59%	1
2019 Q1	$303M	Buy	13,379,979 +1,063,450	+9%	+$27M	24.48%	2
2018 Q4	$315M	Buy	12,316,529 +621,650	+5%	+$16.8M	27.26%	2
2018 Q3	$382M	Buy	11,694,879 +481,000	+4%	+$13.1M	30.43%	1
2018 Q2	$254M	Buy	11,213,879 +315,000	+3%	+$7.48M	30.84%	1
2018 Q1	$264M	Buy	10,898,879 +151,771	+1%	+$4.17M	23.51%	3
2017 Q4	$300M	Buy	10,747,108 +41,000	+0.4%	+$1.21M	20.21%	3
2017 Q3	$367M	Sell	10,706,108 -72	-0%	-$2.35K	16.83%	3
2017 Q2	$427M	Buy	10,706,180 +1,072	+0%	+$41.2K	15.67%	4
2017 Q1	$394M	Buy	10,705,108 +197,500	+2%	+$6.31M	16.31%	4
2016 Q4	$335M	Buy	10,507,608 +1,100,471	+12%	+$34.1M	16.13%	4
2016 Q3	$341M	Buy	9,407,137 +673,500	+8%	+$18.8M	13.78%	5
2016 Q2	$198M	Buy	8,733,637 +1,909,000	+28%	+$41.2M	9.31%	5
2016 Q1	$128M	Buy	6,824,637 +1,763,000	+35%	+$28.8M	5.86%	5
2015 Q4	$83M	Buy	5,061,637 +4,700,952	+1,303%	+$74.6M	3.56%	5
2015 Q3	$3.96M	Buy	+360,685	New	+$4.59M	0.23%	6